Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine in Surgical Patients With Septic Shock
NCT06462313Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dobutamine in septic shock (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Incidence of acute kidney injury after surgery, Sequential Organ Failure Assessment score at Day 7 and 1 more. Started Jun 2024; status: completed.
02
Drugs
dobutamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06462313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462313.